yutopar
Pharmaranks rates Yutopar 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Yutopar (Ritodrine Hydrochloride) is a medication supplied as an injectable and tablet.
Ritodrine Hydrochloride · by Astrazeneca
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Ritodrine Hydrochloride
- Form
- Injectable, Tablet
- Strength
- Ritodrine Hydrochloride 10MG/ML · Ritodrine Hydrochloride 15MG/ML
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Astrazeneca
- FDA application
- NDA018580
- Availability
- Discontinued (per FDA)
Dosage forms
Injectable and Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- How is Yutopar rated?
- pharmaranks gives Yutopar a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Yutopar?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Yutopar. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Yutopar?
- Yutopar is marketed by Astrazeneca. You can see Astrazeneca's full profile, rating, and other products on pharmaranks.
- Is Yutopar a brand-name or generic drug?
- Yutopar is a brand-name product with the active ingredient Ritodrine Hydrochloride.
- Is Yutopar available over the counter?
- No. Yutopar is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Yutopar come in?
- Yutopar is currently marketed as injectable and tablet, per the FDA's National Drug Code Directory.
- Is Yutopar FDA-registered?
- Yutopar is on record with the U.S. FDA under application number NDA018580. You can verify this on its official FDA label.
- Has Yutopar been recalled by the FDA?
- Yutopar has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Yutopar safe?
- There's no single safe-or-not verdict. pharmaranks gives Yutopar a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about RITODRINE HYDROCHLORIDE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 246 reports naming RITODRINE HYDROCHLORIDE — the active ingredient in Yutopar, and the FDA flagged 89% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- exposure during pregnancy52 reports
- premature baby52 reports
- foetal exposure during pregnancy46 reports
- maternal exposure during pregnancy45 reports
- caesarean section34 reports
- drug exposure during pregnancy33 reports
- low birth weight baby27 reports
- premature labour24 reports
Read these as a signal, not a rate. A report does not mean RITODRINE HYDROCHLORIDE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
benzamycin
Benzoyl Peroxide and Erythromycin
colazal
Balsalazide Disodium
cuprimine
Penicillamine
mysoline
Primidone
retin-a
Tretinoin
tolak
Fluorouracil
Compare Yutopar head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
yutopar
70/100